AM

Amar Maulasab Shaikh

Active Director Additional Director DIN 10773545
DIN 10773545 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Amar Maulasab Shaikh

Data last updated:

Amar Maulasab Shaikh is an Additional Director at Absien Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10773545
Primary Designation Additional Director
Industry Pharma
First Appointment 10 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director10 Sep 20242024Active

Board colleagues of Amar Maulasab Shaikh

NameDINCompanyDesignation
Jahangir Dastgir Shaikh10527131Absien Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Absien Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amar Maulasab Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amar Maulasab Shaikh

Amar Maulasab Shaikh currently holds 1 directorship: Absien Pharmaceuticals Private Limited (Additional Director, since 10 Sep 2024).

Amar Maulasab Shaikh was first appointed on 10 Sep 2024 as Additional Director at Absien Pharmaceuticals Private Limited.

The current boards of Amar Maulasab Shaikh's companies include Jahangir Dastgir Shaikh (Absien Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available